Celsion And Medidata Present Findings On Use Of Synthetic Control Arm To Estimate Treatment Effect In Ovarian Cancer Trial At 2022 AACR Annual Meeting; Shares Move Higher
Celsion Corporation (NASDAQ:CLSN) a clinical-stage company focused on DNA-based immunotherapy and next generation vaccines and Medidata, a Dassault Systèmes company, today announced that they presented their